ENTITY
Grifols SA

Grifols SA (GRF SM)

67
Analysis
Health CareSpain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
bullishGrifols SA
01 Jul 2024 00:17

Another Debt Downgrade

​Moody's downgrades Grifols' rating due to high leverage and opaque governance. For risk-tolerant investors, the current low share price could...

Share
bullishGrifols SA
22 Jun 2024 05:04Syndicated

Grifols S A (GRF/P SM) - Friday, Mar 22, 2024

Gotham City Research's short report on Grifols is seen as misguided, creating a buying opportunity for investors. Grifols is still viewed as a...

Logo
379 Views
Share
bullishGrifols SA
16 May 2024 07:14

Liquid Universe of European Ordinary and Preferred Shares: May‘24 Report

Since mid-April, spreads have generally tightened across our European liquid universe of ordinary and preferred shares (12 have tightened, 7...

Share
bearishGrifols SA
18 Apr 2024 00:04

Liquid Universe of European Ordinary and Preferred Shares: April‘24 Report

Since mid-March, spreads have generally widened across our European liquid universe of ordinary and preferred shares (5 have tightened, 12 widened,...

Share
bullishGrifols SA
16 Jan 2024 18:56

Liquid Universe of European Ordinary and Preferred Shares: January‘24 Report

Since mid-December, spreads have generally tightened across our European liquid universe of ordinary and preferred shares. The spread of Grifols...

Share
x